According to the latest report by IMARC Group, titled “North America Active Pharmaceutical Ingredient Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the north america active pharmaceutical ingredients market reached a value of US$ 72.7 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 6.2% during 2021-2026.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Request Free Report Sample:

Active pharmaceutical ingredient (API) refers to a combination of biologically active substances used in a finished pharmaceutical product. Some of the common processes utilized for the production of an API include recombinant deoxyribonucleic acid (DNA), chemical synthesis, isolation, fermentation, and recovery from natural resources. API has a direct effect in correcting, modifying, and restoring physiological functions of the body. As a result, it is largely utilized in the fields of oncology, pulmonology, nephrology, orthopedic, endocrinology, and neurology.

The North America API market growth is being driven by the increasing prevalence of various chronic diseases, such as diabetes and cancer. The introduction of several research and development (R&D) programs for novel drug production and the rising importance of generics are further supporting the market growth. Apart from this, the sudden outbreak of the coronavirus disease (COVID-19) has provided a favorable impact on the market as it has prompted leading players to manufacture large amounts of API to cater to the demand for COVID-19 medications in the region.

North America Active Pharmaceutical Ingredient Market 2021-2026 Competitive Analysis and Segmentation:

Competitive Landscape with Key Players:

The competitive landscape of the north america active pharmaceutical ingredient market has been studied in the report with the detailed profiles of the key players operating in the market.

Key Market Segmentation:

The report has segmented the north america active pharmaceutical ingredient market on the basis of drug type, manufacturer type, synthesis type, product and expression system type, therapeutic application, country.

Breakup by Drug Type:

  • Innovative Active Pharmaceutical Ingredients
  • Generic Active Pharmaceutical Ingredients

Breakup by Manufacturer Type:

  • Captive Manufacturers
  • Merchant API Manufacturers

Breakup by Synthesis Type:

  • Synthetic Active Pharmaceutical Ingredients
  • Biotech Active Pharmaceutical Ingredients

Breakup by Product and Expression System Type:

  • Product Type
  • Expression System Type

Breakup by Therapeutic Application:

  • Oncology
  • Cardiovascular and Respiratory
  • Diabetes
  • Central Nervous System Disorders
  • Neurological Disorders
  • Others

Breakup by Country:

  • United States
  • Canada
  • Mexico

Explore Full Report with TOC & List of Figure:

Key highlights of the report:            

  • Market Performance (2015-2020)
  • Market Outlook (2021-2026)
  • Industry Trends
  • Market Drivers and Success Factors
  • The Impact of COVID-19 on the Global Market
  • Value Chain Analysis
  • Structure of the Global Market
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us                                                                      

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:


30 N Gould St Ste R

Sheridan, WY 82801 USA – Wyoming


Tel No:(D) +91 120 433 0800

Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800